The diverse landscape of RNA modifications in cancer development and progression

Abakir A, Giles TC, Cristini A, Foster JM, Dai N, Starczak M, Rubio-Roldan A, Li M, Eleftheriou M, Crutchley J et al (2020) N(6)-methyladenosine regulates the stability of RNA:DNA hybrids in human cells. Nat Genet 52:48–55

Article  PubMed  CAS  Google Scholar 

Abe M, Naqvi A, Hendriks GJ, Feltzin V, Zhu Y, Grigoriev A, Bonini NM (2014) Impact of age-associated increase in 2’-O-methylation of miRNAs on aging and neurodegeneration in Drosophila. Genes Dev 28:44–57

Article  PubMed  PubMed Central  CAS  Google Scholar 

Akichika S, Hirano S, Shichino Y, Suzuki T, Nishimasu H, Ishitani R, Sugita A, Hirose Y, Iwasaki S, Nureki O, Suzuki T (2019) Cap-specific terminal N (6)-methylation of RNA by an RNA polymerase II-associated methyltransferase. Science 363

Alarcón CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF (2015) N6-methyladenosine marks primary microRNAs for processing. Nature 519:482–485

Article  PubMed  PubMed Central  Google Scholar 

Alarcon CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF (2015a) HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162:1299–1308

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alarcon CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF (2015b) N6-methyladenosine marks primary microRNAs for processing. Nature 519:482–485

Article  PubMed  PubMed Central  CAS  Google Scholar 

Allegra D, Bilan V, Garding A, Dohner H, Stilgenbauer S, Kuchenbauer F, Mertens D, Zucknick M (2014) Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. Leukemia 28:98–107

Article  PubMed  CAS  Google Scholar 

Amin EM, Liu Y, Deng S, Tan KS, Chudgar N, Mayo MW, Sanchez-Vega F, Adusumilli PS, Schultz N, Jones DR (2017) The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK. Sci Signal 10

Amweg A, Tusup M, Cheng P, Picardi E, Dummer R, Levesque MP, French LE, Guenova E, Lauchli S, Kundig T et al (2022) The A to I editing landscape in melanoma and its relation to clinical outcome. RNA Biol 19:996–1006

Article  PubMed  PubMed Central  CAS  Google Scholar 

Angelova MT, Dimitrova DG, Da Silva B, Marchand V, Jacquier C, Achour C, Brazane M, Goyenvalle C, Bourguignon-Igel V, Shehzada S et al (2020) tRNA 2’-O-methylation by a duo of TRM7/FTSJ1 proteins modulates small RNA silencing in Drosophila. Nucleic Acids Res 48:2050–2072

Article  PubMed  PubMed Central  CAS  Google Scholar 

Anita R, Paramasivam A, Priyadharsini JV, Chitra S (2020) The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients. Am J Cancer Res 10:2546–2554

PubMed  PubMed Central  CAS  Google Scholar 

Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millan-Zambrano G, Robson SC, Aspris D, Migliori V, Bannister AJ, Han N et al (2017) Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control. Nature 552:126–131

Article  PubMed  PubMed Central  CAS  Google Scholar 

Barozzi C, Zacchini F, Corradini AG, Morara M, Serra M, De Sanctis V, Bertorelli R, Dassi E, Montanaro L (2023) Alterations of ribosomal RNA pseudouridylation in human breast cancer. NAR Cancer 5:zcad026

Article  PubMed  PubMed Central  Google Scholar 

Bjork GR, Hagervall TG (2005) Transfer RNA Modification. EcoSal Plus 1

Boccaletto P, Stefaniak F, Ray A, Cappannini A, Mukherjee S, Purta E, Kurkowska M, Shirvanizadeh N, Destefanis E, Groza P et al (2022) MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res 50:D231–D235

Article  PubMed  CAS  Google Scholar 

Boo SH, Ha H, Kim YK (2022) m(1)A and m(6)A modifications function cooperatively to facilitate rapid mRNA degradation. Cell Rep 40:111317

Article  PubMed  CAS  Google Scholar 

Boulias K, Toczydlowska-Socha D, Hawley BR, Liberman N, Takashima K, Zaccara S, Guez T, Vasseur JJ, Debart F, Aravind L et al (2019) Identification of the m(6)Am methyltransferase PCIF1 reveals the location and functions of m(6)Am in the transcriptome. Mol Cell 75:631–643

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cao LM, Yu YF, Li ZZ, Zhong NN, Wang GR, Xiao Y, Liu B, Wu QJ, Feng C, Bu LL (2024) Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions. J Nanobiotechnology 22:308

Article  PubMed  PubMed Central  Google Scholar 

Carlile TM, Martinez NM, Schaening C, Su A, Bell TA, Zinshteyn B, Gilbert WV (2019) mRNA structure determines modification by pseudouridine synthase 1. Nat Chem Biol 15:966–974

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cerneckis J, Cui Q, Liu W, Shi Y (2023) RNA modifications in cancer stem cell biology. Cancer Treat Res 190:25–47

Article  PubMed  Google Scholar 

Chan TH, Qamra A, Tan KT, Guo J, Yang H, Qi L, Lin JS, Ng VH, Song Y, Hong H et al (2016) ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer. Gastroenterology 151:637–650

Article  PubMed  CAS  Google Scholar 

Chehelgerdi M, Chehelgerdi M (2023) The use of RNA-based treatments in the field of cancer immunotherapy. Mol Cancer 22:106

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen L, Wang X (2018) Relationship between the genetic expression of WTAP and bladder cancer and patient prognosis. Oncol Lett 16:6966–6970

PubMed  PubMed Central  CAS  Google Scholar 

Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL et al (2013) Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 19:209–216

Article  PubMed  PubMed Central  Google Scholar 

Chen W, He W, Cai H, Hu B, Zheng C, Ke X, Xie L, Zheng Z, Wu X, Wang H (2017) A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer. Oncotarget 8:39417–39429

Article  PubMed  PubMed Central  Google Scholar 

Chen M, Wei L, Law CT, Tsang FHC, Shen J, Cheng CLH, Tsang LH, Ho DWH, Chiu DKC, Lee JMF et al (2018) RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 67:2254–2270

Article  PubMed  CAS  Google Scholar 

Chen X, Li A, Sun BF, Yang Y, Han YN, Yuan X, Chen RX, Wei WS, Liu Y, Gao CC et al (2019) 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol 21:978–990

Article  PubMed  CAS  Google Scholar 

Chen H, Gu L, Orellana EA, Wang Y, Guo J, Liu Q, Wang L, Shen Z, Wu H, Gregory RI et al (2020a) METTL4 is an snRNA m(6)Am methyltransferase that regulates RNA splicing. Cell Res 30:544–547

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T et al (2020b) METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer 19:106

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Pan C, Wang X, Xu D, Ma Y, Hu J, Chen P, Xiang Z, Rao Q, Han X (2021a) Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Theranostics 11:7640–7657

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Z, Zhu W, Zhu S, Sun K, Liao J, Liu H, Dai Z, Han H, Ren X, Yang Q et al (2021b) METTL1 promotes hepatocarcinogenesis via m(7) G tRNA modification-dependent translation control. Clin Transl Med 11:e661

Article  PubMed  PubMed Central  CAS  Google

Comments (0)

No login
gif